Journal of Clinical Endocrinology & Metabolism, Vol 75, 101-105, Copyright © 1992 by Endocrine Society

ARTICLES

Androstenedione metabolism in cultured human osteoblast-like cells

HR Bruch, L Wolf, R Budde, G Romalo and HU Schweikert
Department of Internal Medicine, University of Bonn, Germany.

Bone is a target organ of androgens. The mechanism by which these steroids exert their action within bone cells is still poorly understood. The metabolism of androstenedione, the major circulating androgen in women, was, therefore, assessed in osteoblast-like bone cells cultured from bone of 16 postmenopausal women (mean age, 69 yr; range, 56-80) and 3 elderly men (mean age, 71 yr; range, 69-73) undergoing total hip replacement. Each cell strain was incubated under standardized conditions with varying concentrations of [1,2,6,7- 3H]androstenedione (0.05-5 microM). In every instance 5 alpha-reduced metabolites and 17 beta-hydroxysteroids were formed. There was no correlation between the volumetric density of the resected bone and androstenedione metabolism of the corresponding cultured bone cell strains. The apparent Km for the 5 alpha-reductase activity (sum of androstanedione and dihydrotestosterone) of all 19 cell strains was 0.7 +/- 0.1 microM (mean +/- SEM), and the apparent Km for 17 beta- hydroxysteroid dehydrogenase (sum of testosterone and dihydrotestosterone) was 2.3 +/- 0.8 microM (mean +/- SEM), values similar to those reported for other androgen target organs. Our results demonstrate that human osteoblast-like cells have the capacity to transform androstenedione into the more potent biological androgens testosterone and dihydrotestosterone. Since the Km values of both 5 alpha-reductase and 17 beta-hydroxysteroid dehydrogenase exceed the serum androstenedione concentration, the formation of testosterone and dihydrotestosterone appears to be mainly a function of substrate availability.

This article has been cited by other articles:

				A S Chagin, D Chrysis, M Takigawa, E M Ritzen, and L Savendahl Locally produced estrogen promotes fetal rat metatarsal bone growth; an effect mediated through increased chondrocyte proliferation and decreased apoptosis J. Endocrinol., February 1, 2006; 188(2): 193 - 203. [Abstract] [Full Text] [PDF]

				R. M. Lovering and W. A. Romani Effect of testosterone on the female anterior cruciate ligament Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R15 - R22. [Abstract] [Full Text] [PDF]

				M. Muir, G. Romalo, L. Wolf, W. Elger, and H.-U. Schweikert Estrone Sulfate Is a Major Source of Local Estrogen Formation in Human Bone J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4685 - 4692. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF]

				J. Compston Local Biosynthesis of Sex Steroids in Bone J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5398 - 5400. [Full Text] [PDF]

				S. Issa, D. Schnabel, M. Feix, L. Wolf, H.-E. Schaefer, D. W. Russell, and H.-U. Schweikert Human Osteoblast-Like Cells Express Predominantly Steroid 5{alpha}-Reductase Type 1 J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5401 - 5407. [Abstract] [Full Text] [PDF]

				G. L. Rubin, J. H. Duong, C. D. Clyne, C. J. Speed, Y. Murata, C. Gong, and E. R. Simpson Ligands for the Peroxisomal Proliferator-Activated Receptor {gamma} and the Retinoid X Receptor Inhibit Aromatase Cytochrome P450 (CYP19) Expression Mediated by Promoter II in Human Breast Adipose Endocrinology, August 1, 2002; 143(8): 2863 - 2871. [Abstract] [Full Text] [PDF]

				B. L. Riggs, S. Khosla, and L. J. Melton III Sex Steroids and the Construction and Conservation of the Adult Skeleton Endocr. Rev., June 1, 2002; 23(3): 279 - 302. [Abstract] [Full Text] [PDF]

				J. E. Compston Sex Steroids and Bone Physiol Rev, January 1, 2001; 81(1): 419 - 447. [Abstract] [Full Text] [PDF]

				J. V. Zborowski, J. A. Cauley, E. O. Talbott, D. S. Guzick, and S. J. Winters Bone Mineral Density, Androgens, and the Polycystic Ovary: The Complex and Controversial Issue of Androgenic Influence in Female Bone J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3496 - 3506. [Full Text]

				G. L. Rubin, Y. Zhao, A. M. Kalus, and E. R. Simpson Peroxisome Proliferator-activated Receptor {{gamma}} Ligands Inhibit Estrogen Biosynthesis in Human Breast Adipose Tissue: Possible Implications for Breast Cancer Therapy Cancer Res., March 1, 2000; 60(6): 1604 - 1608. [Abstract] [Full Text]

				Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4677 - 4694. [Abstract] [Full Text]

				C. J. Rosen Serum Insulin-like Growth Factors and Insulin-like Growth Factor-binding Proteins: Clinical Implications Clin. Chem., August 1, 1999; 45(8): 1384 - 1390. [Abstract] [Full Text] [PDF]

				L. Pederson, M. Kremer, J. Judd, D. Pascoe, T. C. Spelsberg, B. L. Riggs, and M. J. Oursler Androgens regulate bone resorption activity of isolated osteoclasts in vitro PNAS, January 19, 1999; 96(2): 505 - 510. [Abstract] [Full Text] [PDF]

				B. Stoffel-Wagner, M. Watzka, S. Steckelbroeck, L. Wickert, J. Schramm, G. Romalo, D. Klingmüller, and H.-U. Schweikert Expression of 5{alpha}-Reductase in the Human Temporal Lobe of Children and Adults J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3636 - 3642. [Abstract] [Full Text]

				E. Simpson Why Do the Clinical Sequelae of Estrogen Deficiency Affect Women More than Men?a J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2214 - 2215. [Full Text]

				M. Shozu, Y. Zhao, and E. R. Simpson Estrogen Biosynthesis in THP1 Cells Is Regulated by Promoter Switching of the Aromatase (CYP19) Gene Endocrinology, December 1, 1997; 138(12): 5125 - 5135. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, E. Van Herck, J. Nijs, A. G. H. Ederveen, R. De Coster, and R. Bouillon Aromatase Inhibition Impairs Skeletal Modeling and Decreases Bone Mineral Density in Growing Male Rats Endocrinology, June 1, 1997; 138(6): 2301 - 2307. [Abstract] [Full Text] [PDF]